Protein fibrilization and Parkinson's disease.

被引：0
|
作者：
Lansbury, PT [1 ]
Ding, T [1 ]
Lashuel, H [1 ]
Rochet, DC [1 ]
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Cambridge, MA 02139 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 223卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
147-PHYS
引用
收藏
页码：C41 / C42
页数：2
相关论文
共 50 条
  • [21] Treatment of Parkinson's disease. Duodopa®
    Valldeoriola, F.
    REVISTA DE NEUROLOGIA, 2010, 50 : S34 - S36
  • [22] Sentence comprehension in Parkinson's disease.
    Grossman, M
    BRAIN AND COGNITION, 1996, 30 (03) : 19 - 19
  • [23] Neuropsychiatric aspects of Parkinson's disease.
    Aarsland D.
    Karlsen K.
    Current Psychiatry Reports, 1999, 1 (1) : 61 - 68
  • [24] Levodopa and the progression of Parkinson's disease.
    Morgan J.
    Sethi K.D.
    Current Neurology and Neuroscience Reports, 2005, 5 (4) : 261 - 262
  • [25] Amantadine in the therapy of Parkinson's disease.
    Baumhackl, U
    Klingler, D
    NEUROPSYCHIATRIE, 1995, 9 : S23 - S24
  • [26] The personality associated with Parkinson's disease.
    Menza M.
    Current Psychiatry Reports, 2000, 2 (5) : 421 - 426
  • [27] Psychiatric symptoms in Parkinson's disease.
    Anderson K.E.
    Weiner W.J.
    Current Neurology and Neuroscience Reports, 2002, 2 (4) : 303 - 309
  • [28] Combined treatment in Parkinson's disease.
    Reisecker, F
    Ladurner, G
    NEUROPSYCHIATRIE, 1995, 9 : S27 - S29
  • [29] Cell therapy for Parkinson's disease.
    Fischbach, GD
    McKhann, GM
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10): : 763 - 765
  • [30] Camptocormia in patients with Parkinson's disease.
    Etchepare, F
    Fautrel, B
    Bonnet, AM
    Rozenberg, S
    Lecorre, C
    Koeger, AC
    Agid, Y
    Bourgeois, P
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S218 - S218
12345